Corrigendum to “Epidermal growth factor receptors siRNA-conjugated collagen modified gold nanoparticles for targeted imaging and therapy of lung cancer” [Mater. Today Adv. 12 (2021), 100191]

• A.Y.-H Yu,
• R.-H. Fu,
• S.-H. Hsu,
• C.-F. Chiu,
• W.-H. Fang,
• C.-A. Yeh,
• C.-M. Tang,
• H.-H. Hsieh,
• H.-S. Hung

Affiliations

A.Y.-H Yu

Ministry of Health & Welfare, Changhua Hospital, Changhua, Taiwan, ROC

R.-H. Fu

Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC; Translational Medicine Research, China Medical University Hospital, Taichung, Taiwan, ROC

S.-H. Hsu

Institute of Polymer Science and Engineering, National Taiwan University, Taipei, Taiwan, ROC

C.-F. Chiu

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC; Division of Chest, Department of Internal Medicine, Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan, ROC

W.-H. Fang

Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC

C.-A. Yeh

Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC

C.-M. Tang

College of Oral Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC

H.-H. Hsieh

Blood Bank, Taichung Veterans General Hospital, Taichung, Taiwan, ROC

H.-S. Hung

Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC; Translational Medicine Research, China Medical University Hospital, Taichung, Taiwan, ROC; Corresponding author. Graduate Institute of Biomedical Science, China Medical University, Taichung, 40402, Taiwan, ROC.